Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001096906-15-001149
Filing Date
2015-11-13
Accepted
2015-11-13 08:30:56
Documents
11
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 AOXING PHARMACEUTICAL COMPANY, INC. 10Q 2015-09-30 aoxing10q.htm 10-Q 473228
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxing311.htm EX-31.1 7364
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SOX OF 2 aoxing312.htm EX-31.2 7330
4 CERTIFICATE OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxing321.htm EX-32.1 4046
5 CERTIFICATE OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C.SS.1350. aoxing322.htm EX-32.2 4131
  Complete submission text file 0001096906-15-001149.txt   2601013

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT axn-20150930.xml EX-101.INS 522301
7 XBRL TAXONOMY EXTENSION SCHEMA axn-20150930.xsd EX-101.SCH 30461
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axn-20150930_cal.xml EX-101.CAL 32496
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axn-20150930_def.xml EX-101.DEF 34783
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE axn-20150930_lab.xml EX-101.LAB 152037
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axn-20150930_pre.xml EX-101.PRE 134173
Mailing Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310
Business Address 444 WASHINGTON BLVD SUITE 3338 JERSEY CITY NJ 07310 646-367-1747
AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-32674 | Film No.: 151226999
SIC: 2834 Pharmaceutical Preparations